Huntington National Bank’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Huntington National Bank’s Portfolio ICPT Stock Details ICPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-190	Closed	-$24K	–	1920
2019 Q4	$24K	Buy	+190	New	+$17K	﹤0.01%	1206
2019 Q3	–	Sell	-50	Closed	-$4K	–	1843
2019 Q2	$4K	Hold	50	–	–	﹤0.01%	1460
2019 Q1	$6K	Hold	50	–	–	﹤0.01%	1366
2018 Q4	$5K	Hold	50	–	–	﹤0.01%	1451
2018 Q3	$6K	Hold	50	–	–	﹤0.01%	1488
2018 Q2	$4K	Hold	50	–	–	﹤0.01%	1481
2018 Q1	$3K	Hold	50	–	–	﹤0.01%	1493
2017 Q4	$3K	Hold	50	–	–	﹤0.01%	1546
2017 Q3	$3K	Hold	50	–	–	﹤0.01%	1535
2017 Q2	$6K	Hold	50	–	–	﹤0.01%	1367
2017 Q1	$6K	Hold	50	–	–	﹤0.01%	1240
2016 Q4	$5K	Hold	50	–	–	﹤0.01%	1308
2016 Q3	$8K	Hold	50	–	–	﹤0.01%	1280
2016 Q2	$7K	Hold	50	–	–	﹤0.01%	1293
2016 Q1	$14K	Hold	50	–	–	﹤0.01%	1425
2015 Q4	$7K	Hold	50	–	–	﹤0.01%	1413
2015 Q3	$8K	Hold	50	–	–	﹤0.01%	1454
2015 Q2	$12K	Hold	50	–	–	﹤0.01%	1468
2015 Q1	$14K	Hold	50	–	–	﹤0.01%	1434
2014 Q4	$8K	Buy	+50	New	+$9.23K	﹤0.01%	1486

Other funds holding ICPT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Huntington National Bank's ICPT Position: Q1 2020 in Review

Huntington National Bank sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q1 2020, closing a stake of 190 shares — an estimated $24K sold.

Huntington National Bank first reported a position in ICPT in Q4 2014 and held it in 20 quarters. The position peaked at $24K in Q4 2019. 188 funds tracked by Wall St. Rank hold ICPT as of Q1 2020.

Huntington National Bank reported no remaining Intercept Pharmaceuticals, Inc. position as of Q1 2020 after selling out during the quarter.
Huntington National Bank sold 190 Intercept Pharmaceuticals, Inc. shares in Q1 2020, an estimated $24K.
Huntington National Bank first reported a position in Intercept Pharmaceuticals, Inc. in Q4 2014 and held it in 20 quarters.
Huntington National Bank's Intercept Pharmaceuticals, Inc. position peaked at $24K in Q4 2019.
188 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q1 2020.

Based on Huntington National Bank's 13F filing for Q1 2020, filed 27 Apr 2020.